CASM has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
CASM has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.
CAS Medical Systems's adjusted revenue per share for the three months ended in Dec. 2018 was $0.208. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $0.00 for the trailing ten years ended in Dec. 2018.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.
As of today (2024-05-05), CAS Medical Systems's current stock price is $2.45. CAS Medical Systems's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2018 was $0.00. CAS Medical Systems's Cyclically Adjusted PS Ratio of today is .
The historical data trend for CAS Medical Systems's Cyclically Adjusted Revenue per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CAS Medical Systems Quarterly Data | ||||||||||||||||||||
Mar14 | Jun14 | Sep14 | Dec14 | Mar15 | Jun15 | Sep15 | Dec15 | Mar16 | Jun16 | Sep16 | Dec16 | Mar17 | Jun17 | Sep17 | Dec17 | Mar18 | Jun18 | Sep18 | Dec18 | |
Cyclically Adjusted Revenue per Share | Get a 7-Day Free Trial | - | - | - | - | - |
For the Medical Instruments & Supplies subindustry, CAS Medical Systems's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, CAS Medical Systems's Cyclically Adjusted PS Ratio distribution charts can be found below:
* The bar in red indicates where CAS Medical Systems's Cyclically Adjusted PS Ratio falls into.
E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.
What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?
Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.
If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.
We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
For example, CAS Medical Systems's adjusted Revenue per Share data for the three months ended in Dec. 2018 was:
Adj_RevenuePerShare | = | Revenue per Share | / | CPI of Dec. 2018 (Change) | * | Current CPI (Dec. 2018) |
= | 0.208 | / | 105.9979 | * | 105.9979 | |
= | 0.208 |
Current CPI (Dec. 2018) = 105.9979.
CAS Medical Systems Quarterly Data
Revenue per Share | CPI | Adj_RevenuePerShare | |
200903 | 0.750 | 89.744 | 0.886 |
200906 | 0.763 | 91.003 | 0.889 |
200909 | 0.780 | 91.120 | 0.907 |
200912 | 0.716 | 91.111 | 0.833 |
201003 | 0.694 | 91.821 | 0.801 |
201006 | 0.708 | 91.962 | 0.816 |
201009 | 0.608 | 92.162 | 0.699 |
201012 | -0.033 | 92.474 | -0.038 |
201103 | 0.434 | 94.283 | 0.488 |
201106 | 0.437 | 95.235 | 0.486 |
201109 | 0.440 | 95.727 | 0.487 |
201112 | 0.403 | 95.213 | 0.449 |
201203 | 0.409 | 96.783 | 0.448 |
201206 | 0.392 | 96.819 | 0.429 |
201209 | 0.459 | 97.633 | 0.498 |
201212 | 0.446 | 96.871 | 0.488 |
201303 | 0.416 | 98.209 | 0.449 |
201306 | 0.376 | 98.518 | 0.405 |
201309 | 0.306 | 98.790 | 0.328 |
201312 | 0.316 | 98.326 | 0.341 |
201403 | 0.298 | 99.695 | 0.317 |
201406 | 0.304 | 100.560 | 0.320 |
201409 | 0.287 | 100.428 | 0.303 |
201412 | 0.304 | 99.070 | 0.325 |
201503 | 0.255 | 99.621 | 0.271 |
201506 | 0.218 | 100.684 | 0.230 |
201509 | 0.205 | 100.392 | 0.216 |
201512 | 0.218 | 99.792 | 0.232 |
201603 | 0.204 | 100.470 | 0.215 |
201606 | 0.206 | 101.688 | 0.215 |
201609 | 0.215 | 101.861 | 0.224 |
201612 | 0.204 | 101.863 | 0.212 |
201703 | 0.193 | 102.862 | 0.199 |
201706 | 0.167 | 103.349 | 0.171 |
201709 | 0.166 | 104.136 | 0.169 |
201712 | 0.187 | 104.011 | 0.191 |
201803 | 0.197 | 105.290 | 0.198 |
201806 | 0.191 | 106.317 | 0.190 |
201809 | 0.193 | 106.507 | 0.192 |
201812 | 0.208 | 105.998 | 0.208 |
Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.
If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.
For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.
Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.
Thank you for viewing the detailed overview of CAS Medical Systems's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Alan Milinazzo | director | C/O ORTHOFIX INC, 10115 KINCEY AVENUE STE 250, HUNTERSVILLE NC 28078 |
Thomas M Patton | director, officer: President and CEO | C/O OSTEOTCH INC., 51 JAMES WAY, EATONTOWN NJ 07724 |
Kenneth R Weisshaar | director | 875 PARK AVE APT 2D, NEW YORK NY 10021 |
James E Thomas | director, 10 percent owner | WOODS END ROAD, NEW CANAAN CT 06840 |
Thomas, Mcnerney & Partners Ii L.p. | 10 percent owner | 45 SOUTH 7TH STREET, SUITE 3060, Minneapolis MN 55402 |
Tmp Associates Ii Lp | 10 percent owner | 45 SOUTH SEVENTH STREET, SUITE 3060, MINNEAPOLIS MN 55402 |
Tmp Nominee Ii, Llc | 10 percent owner | 45 SOUTH SEVENTH STREET, SUITE 3060, MINNEAPOLIS MN 55402 |
Thomas, Mcnerney & Partners Ii, Llc | 10 percent owner | 45 SOUTH SEVENTH STREET, SUITE 3060, MINNEAPOLIS MN 55402 |
Acuta Capital Fund, Lp | 10 percent owner | 1301 SHOREWAY ROAD, SUITE 350, BELMONT CA 94002 |
James E Flynn | 10 percent owner, other: Possible Member of 10% Group | 780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017 |
Deerfield Management Company, L.p. (series C) | 10 percent owner, other: Possible Member of 10% Group | 345 PARK AVENUE SOUTH, 12TH FLOOR, NEW YORK NY 10010 |
Deerfield Mgmt L.p. | 10 percent owner, other: Possible Member of 10% Group | 780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017 |
Deerfield Special Situations Fund, L.p. | 10 percent owner, other: Possible Member of 10% Group | 780 3RD AVENUE, 37TH FLOOR, NEW YORK NY 10017 |
Deerfield Special Situations International Master Fund, L.p. | 10 percent owner, other: Possible Member of 10% Group | 780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017 |
Lawrence Burstein | director | C/O UNITY VENTURE CAPITAL ASSOCIATES LTD, 245 FIFTH AVENUE, SUITE 1500, NEW YORK NY 10016 |
From GuruFocus
By Marketwired Marketwired • 03-28-2019
By Marketwired Marketwired • 01-04-2019
By Marketwired Marketwired • 03-05-2019
By Marketwired Marketwired • 10-24-2018
By gurufocus 10qk • 08-04-2010
By GuruFocus Research GuruFocus Editor • 12-08-2010
By PRNewswire PRNewswire • 02-15-2019
By PRNewswire PRNewswire • 02-27-2019
By gurufocus 10qk • 11-05-2009
By Marketwired Marketwired • 05-03-2018